NEW YORK (GenomeWeb) – Thermo Fisher Scientific reported before the opening of the market on Thursday that its second quarter revenues increased 6 percent, thanks in part to large increases in laboratory products and services revenues and life sciences solutions revenues.

Separately today, Thermo Fisher said that it has signed a deal with Health BioMed to support that company's efforts to develop molecular diagnostic kits for infectious disease and pharmacogenomics screening for the Chinese market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.